142 related articles for article (PubMed ID: 16039177)
1. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection.
Perrot E; Guibert B; Mulsant P; Blandin S; Arnaud I; Roy P; Geriniere L; Souquet PJ
Ann Thorac Surg; 2005 Aug; 80(2):423-7. PubMed ID: 16039177
[TBL] [Abstract][Full Text] [Related]
2. Sleeve lobectomy compared with pneumonectomy after induction therapy for non-small-cell lung cancer.
Maurizi G; D'Andrilli A; Anile M; Ciccone AM; Ibrahim M; Venuta F; Rendina EA
J Thorac Oncol; 2013 May; 8(5):637-43. PubMed ID: 23584296
[TBL] [Abstract][Full Text] [Related]
3. Is pneumonectomy after induction chemotherapy for non-small cell lung cancer a reasonable procedure? A multicenter retrospective study of 228 cases.
Thibout Y; Guibert B; Bossard N; Tronc F; Tiffet O; de la Roche E; Mulsant P; Gamondes JP; Baulieux J; Remontet L; Geriniere L; Souquet PJ
J Thorac Oncol; 2009 Dec; 4(12):1496-503. PubMed ID: 19745768
[TBL] [Abstract][Full Text] [Related]
4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
5. Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer.
Torre W; Sierra A
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):539-44. PubMed ID: 12124570
[TBL] [Abstract][Full Text] [Related]
6. Effect analysis of chemoradiotherapy after operation in patients with stage III A non-small cell lung cancer.
Chen S; Cheng YL; Li ST; Ni YJ; Gu B
Asian Pac J Trop Med; 2012 Oct; 5(10):823-7. PubMed ID: 23043924
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy.
Martin J; Ginsberg RJ; Abolhoda A; Bains MS; Downey RJ; Korst RJ; Weigel TL; Kris MG; Venkatraman ES; Rusch VW
Ann Thorac Surg; 2001 Oct; 72(4):1149-54. PubMed ID: 11603428
[TBL] [Abstract][Full Text] [Related]
9. Preoperative chemotherapy for lung cancer does not increase surgical morbidity.
Siegenthaler MP; Pisters KM; Merriman KW; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA; Smythe WR; Putnam JB
Ann Thorac Surg; 2001 Apr; 71(4):1105-11; discussion 1111-2. PubMed ID: 11308144
[TBL] [Abstract][Full Text] [Related]
10. Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party.
Berghmans T; Lafitte JJ; Giner V; Berchier MC; Scherpereel A; Lewin D; Paesmans M; Meert AP; Bosschaerts T; Leclercq N; Sculier JP;
Lung Cancer; 2012 Sep; 77(3):605-10. PubMed ID: 22704426
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine-cisplatin chemotherapy before lung resection: a case-matched analysis of early outcome.
Brunelli A; Xiume' F; Al Refai M; Salati M; Marasco R; Sabbatini A
Ann Thorac Surg; 2006 Jun; 81(6):1963-8. PubMed ID: 16731114
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
Greco FA; Gray JR; Thompson DS; Burris HA; Erland JB; Barton JH; Litchy S; Houston GA; Butts JA; Webb C; Scott C; Hainsworth JD
Cancer; 2002 Sep; 95(6):1279-85. PubMed ID: 12216096
[TBL] [Abstract][Full Text] [Related]
14. What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Boudaya MS; Smadhi H; Marghli A; Charmiti F; Ouerghi S; Mohamed J; Brahem E; Smati B; Mestiri T; Kilani T
Asian Cardiovasc Thorac Ann; 2013 Aug; 21(4):432-6. PubMed ID: 24570525
[TBL] [Abstract][Full Text] [Related]
15. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Pectasides D; Kalofonos HP; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G
Anticancer Res; 2001; 21(4B):3005-10. PubMed ID: 11712802
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.
Dingemans AM; Bootsma G; van Baardwijk A; Reymen B; Wanders R; Brans B; Das M; Hochstenbag M; van Belle A; Houben R; Lambin P; de Ruysscher D
J Thorac Oncol; 2014 May; 9(5):710-6. PubMed ID: 24722157
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant vinorelbine and cisplatin after complete resection of stage II and III non-small cell lung cancer: long-term follow-up of our study of Japanese patients.
Sonobe M; Hamaji M; Motoyama H; Menju T; Aoyama A; Chen-Yoshikawa TF; Sato T; Date H
Surg Today; 2018 Jul; 48(7):687-694. PubMed ID: 29502152
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer.
Luo J; Leaw SJ; Xu Y; Zheng D
Med Oncol; 2011 Dec; 28(4):1418-24. PubMed ID: 20661668
[TBL] [Abstract][Full Text] [Related]
19. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
20. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer.
Rivera MP; Detterbeck FC; Socinski MA; Moore DT; Edelman MJ; Jahan TM; Ansari RH; Luketich JD; Peng G; Monberg M; Obasaju CK; Gralla RJ
Chest; 2009 Jun; 135(6):1588-1595. PubMed ID: 19188545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
